Key Record Dates
ClinicalTrials.gov Identifier: | NCT03398148 |
---|---|
Brief Title: | A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis |
First Submitted : | January 8, 2018 |
First Submitted that Met QC Criteria : | January 8, 2018 |
First Posted : | January 12, 2018 |
Last Update Submitted that Met QC Criteria : | June 1, 2023 |
Last Update Posted : | June 2, 2023 |